VUMC addresses immigration enforcement in medical facilities
NASHVILLE, Tenn. (WKRN) — Illegal immigration is not just a border issue. It's being felt across America, including Middle Tennessee medical facilities.
At Vanderbilt Health, which has seven hospitals and more than 200 clinics across the region, the issue of patient confidentiality, immigration status, and law enforcement requests for information has become a topic of inquiry.
Tennessee Senate passes controversial immigration bill that some call unconstitutional
On Thursday, Feb. 6, Vanderbilt University Medical Center (VUMC) clarified what employees should expect and what they should do in certain circumstances. In a lengthy document, officials discussed policies but also presented questions healthcare workers might have and scenarios they might face.
For example, one of the questions was 'What should I do if ICE or other law enforcement agents appear in my unit?'
In that case, the Office of Legal Affairs instructed employees to interact with authorities in a calm and professional manner without any physical contact, resistance, interference, or misstatements even if the law enforcement agents are uncooperative or aggressive. Employees were also urged not to share any patient information, including immigration status, with authorities or grant them access to any non-public areas
'Let's see what happens': Tennessee Republicans look to challenge Supreme Court ruling with bill on undocumented students
The document also specified where authorities could enter and carry out law enforcement activities, what to do if they presented a warrant or were uncooperative, and more.
According to officials, if authorities insist on taking custody of a patient, employees should remain calm, polite, and professional; avoid becoming confrontational or physically interfering with law enforcement; and be truthful but don't hesitate to disclose a lack of authorization to provide certain information.
VUMC said part of its policy is to protect patients' privacy rights while also cooperating with law enforcement agencies to protect the public.
⏩
U.S. Rep. John Rose (R-Tenn.) spoke to a room full of law enforcement on Friday, Feb. 7 at the Tennessee Sheriffs' Association's Exhibitor Winter Annual Conference in Murfreesboro. While the congressman didn't address VUMC's release specifically, he did speak at length about illegal immigration and efforts to curtail it.
'With Republicans in control of the Senate and House now and with President Trump in the White House, we've seen bills like the Laken Riley Act passed and become law,' Rose said. 'It's common sense legislation: it says if a person is already in the country illegally and they commit a host of different crimes, they are going to be immediately deported. We shouldn't have illegal immigrant here to begin with, but certainly if they're causing trouble in our communities, we should get them out of the country.'
VUMC officials declined to comment on the document, telling News 2 the statement is a specific and complete representation of VUMC's position on the matter. However, News 2 learned there have been no instances of Immigration and Customs Enforcement (ICE) agents coming into the hospital.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Moderna's mRNA RSV vaccine wins expanded FDA approval for younger adults
The US Food and Drug Administration (FDA) has expanded approval of Moderna's respiratory syncytial virus (RSV) vaccine to include younger adults at risk, though its still uncertain whether the shot will be recommended for broader use in the national immunisation schedule. Moderna's vaccine, known under the brand name mRESVIA, became the first non-Covid-19 messenger RNA-based (mRNA) vaccine to be approved in the US in May 2024. Until now, the vaccine was licensed for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults aged 60 years and older. The expanded approval now includes individuals aged 18 to 59 who are at risk of RSV. This approval was supported by results from Moderna's Phase III study (NCT06067230), which demonstrated the vaccine's immune response worked just as well in this age group compared to the existing approved age group of 60 years and older. Infants and older adults remain the most vulnerable age groups to RSV, though over one-third of adults between 18 and 59 years of age have at least one underlying condition that puts them at increased risk of developing a severe form of the disease. "RSV poses a serious health risk to adults with certain chronic conditions, and today's approval marks an important step forward in our ability to protect additional populations from severe illness from RSV," said Stéphane Bancel, Chief Executive Officer of Moderna. Moderna said it plans to have mRESVIA available for both both younger adults and older adults in the US in time for the 2025-2026 respiratory virus season. This usually begins around November and peaks in the mid-Winter months. mRESVIA is the second approved product in the US for Moderna, along with its Covid-19 vaccine Spikevax. The pharma company has been seeking outside investment to fund late-stage trials for further infectious disease vaccine candidates, amid a strategy to diversify its portfolio. Whilst the label expansion reflects an easing in regulatory tension surrounding mRNA vaccines under the Trump administration, FDA approval does not automatically mean shots enter national immunisation schedules. That is instead decided by the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP). The CDC currently recommends the vaccine for adults aged 75 and older, as well as for adults aged 60 to 74 who are at increased risk of infection. In April, the CDC's ACIP recommended the use of approved RSV vaccines in at-risk adults aged 50 to 59. This week, US health secretary Robert F Kennedy (RFK) Jr axed the entire ACIP panel of experts, replacing members with vaccine sceptics and individuals with no prior public health strategy experience. The reshuffle has raised concerns about the future of the US immunisation schedule and the scope of vaccine recommendations. 'Investor focus will likely shift to the CDC's ACIP's next meeting, which is scheduled to proceed on June 25-27,' said William Blair analyst Miles Minter in a research note. 'This will be the first time for investors to see the refreshed ACIP in action and will be important for sentiment in the vaccine sector, which continues to decline in our view. Ultimately, we see the biggest headwind to the RSV vaccination market as restrictive ACIP recommendations that do not include re-dosing potential,' Minter added. The label expansion sees Moderna catch up with Pfizer, which already has an RSV vaccine approved for adults aged 18 years and over. Like mRESVIA, Pfizer's Abrysvo has the requirement of increased disease risk for those between 18 and 59, whilst anyone above the age of 60 is eligible for the jab. Pfizer still has a market advantage, however, with Abrysvo the only vaccine product approved for infants. It also gained FDA approval a year before mRESVIA, giving it first to market advantage. GSK also has an FDA-approved vaccine in the form of Arexvy, though its label only covers those at risk in individuals aged between 50 through 59 years, along with the standard indication of ages 60 and over. "Moderna's mRNA RSV vaccine wins expanded FDA approval for younger adults" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
New York Times
an hour ago
- New York Times
Trump Administration Live Updates: Tariffs Are Planned for Appliances Made With Steel
A law that expired last year was meant to compensate civilians sickened by the legacy of the nation's aboveground nuclear testing program, as well as uranium miners. Senate Republicans on Thursday included in their version of President Trump's domestic policy bill a provision that would revive and significantly expand a law for compensating victims of government-caused nuclear contamination who developed cancer and other serious illnesses. The measure, long championed by Senator Josh Hawley, Republican of Missouri, would overhaul a law passed more than three decades ago with a narrow scope. It was meant to compensate civilians sickened by the legacy of the nation's aboveground nuclear testing program, a hallmark of the Manhattan Project in the 1940s, and uranium miners who worked between 1942 and 1971. It paid out more than $2.6 billion in benefits to more than 55,000 claimants since its creation in 1990. The Senate passed bipartisan legislation last year to substantially broaden the scope of that law — called the Radiation Exposure Compensation Act, or RECA — beyond Cold War-era victims to cover others who have been harmed by the aftereffects in the decades since. But after Republican leaders refused to allow it to come to a vote on the House floor, the law expired, dashing hopes of compensation for sickened civilians. Senate Republican leaders are now, at the behest of Mr. Hawley, giving the measure another shot at passage, including it in the Senate version of the domestic policy bill that they are hoping to pass in weeks. He is considered a key vote on the bill because he opposes several provisions floated by his party for cutting Medicaid. 'I think about, in the St. Louis area alone, how many folks I've talked to whose grandfathers or grandmothers were involved with the radiation project and whose families have subsequently had cancer in the family for generations,' Mr. Hawley said in an interview. 'And they're very proud of their service to the nation, but they would like to be thanked for that and be treated appropriately and not lied to anymore by their government.' The measure would revive the law and authorize its compensation fund to run for another two years. It would also expand eligibility to include civilians in the swaths of New Mexico, Utah and Arizona that were previously excluded from benefits coverage. And it would for the first time allow residents in Missouri, Tennessee, Kentucky and Alaska — sites where workers processed uranium for the nation's nuclear program — who were exposed to nuclear contamination to be eligible for benefits. Mr. Hawley's involvement in the issue stems from St. Louis's history with the atomic bomb. Scientists first began churning out uranium for the Manhattan Project in 1942 at the Mallinckrodt Chemical Works factory there. But over the next several decades, hundreds of thousands of tons of radioactive waste stored in open steel drums were hauled and dumped across the city. The waste seeped into the city's soil, including on land that later became ball fields, and into Coldwater Creek, a tributary that snakes through the metropolitan area for 19 miles through backyards and public parks. Rare cancers, autoimmune diseases and other mysterious illnesses have since spread through the community. Lawmakers like Mr. Hawley have maintained that the government should help foot residents' health care bills. Asked whether the inclusion of the measure might encourage him to support his party's domestic policy bill despite his concerns about the legislation's Medicaid provisions, Mr. Hawley suggested that it could. 'This will really dramatically increase the availability of health care for people in my state,' he said. 'If you are a RECA claimant, if you are a nuclear radiation survivor, then you're going to get a lot of help with your medical bills here. So what this is going to mean, practically in Missouri, is a lot of people are going to get a lot more access to health care, which is really, really important.' Mr. Hawley continued: 'So, I still have concerns about Medicaid, and believe me, I'm talking about those on an almost hourly basis now with my leadership. But this is a big, big deal, and not just for my state. This is going to be a big deal for a lot of people, and it's going to help a lot of people get health care.'
Newsweek
2 hours ago
- Newsweek
The Bulletin June 12, 2025
The rundown: With labor market uncertainty, jobs rewarding employees for "going the extra mile" and competing responsibilities inside and outside the workplace, a growing number of Americans are suffering from what experts refer to as "time poverty." Learn more about what it means. Why it matters: The term has been increasingly adopted by psychologists to denote the chronic imbalance between the time a person needs and that which their work life allows them. A new survey by wellness firm Wondr Health revealed the extent of the issue, finding that the majority (62 percent) of U.S. workers do not take their allotted time off because of the internalized pressures of work and let about one-third of their annual vacation days go unspent. Read more in-depth coverage: Trump-Era Economic Shifts Driving Up U.S. Worker Stress Levels TL/DR: "No one is harder on most of us than ourselves and it leads to time poverty, a condition where we simply do not have enough time for a meaningful work-life balance," said Dr. Tim Church, chief medical officer at Wondr Health. What happens now? Experts pointed to the need for allotted "mental health days," as well as the willingness of businesses to invest in employee wellness programs and foster open communication with their workforces. Deeper reading Americans Are Suffering From 'Time Poverty'
